Copyright: ©Author(s) 2026.
World J Diabetes. Apr 15, 2026; 17(4): 115437
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115437
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115437
Figure 4 Inhibition of nephrocystin-4 improves renal function in diabetic nephropathy mice.
A: Serum creatinine content; B: Blood urea nitrogen content; C: Urinary protein content; D: Hematoxylin and eosin staining of renal tissue; E: Masson staining of renal tissue. Scale bar = 50 µm. Data are presented as mean ± SD (n = 3). aP < 0.05, bP < 0.01, and cP < 0.001. BUN: Blood urea nitrogen; HFD: High-fat diet; Scr: Serum creatinine; STZ: Streptozotocin.
- Citation: Si W, Dai Y, Hu GP, Zhang Q, Lv F, Zhang Q. EP300 drives renal fibrosis in diabetic nephropathy via histone acetyltransferase-mediated nephrocystin-4 expression. World J Diabetes 2026; 17(4): 115437
- URL: https://www.wjgnet.com/1948-9358/full/v17/i4/115437.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i4.115437